Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
54.93
+0.07 (+0.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi-Aventis S.A. ADR
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
31
32
Next >
If Sanofi Opted For Takeover Of Horizon Therapeutics, It Would Be In Cash
December 02, 2022
Via
Benzinga
Why Horizon Therapeutics Stock Is Skyrocketing Today
November 30, 2022
Three big drugmakers could be interested in acquiring Horizon.
Via
The Motley Fool
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
November 30, 2022
Horizon Therapeutics (HZNP) stock is rising higher on Wednesday following reports that the company is considering a buyout.
Via
InvestorPlace
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?
November 30, 2022
Tech layoffs are in the news, but life sciences companies seem to be doing better.
Via
The Motley Fool
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
November 30, 2022
Via
Benzinga
Europe Approves Sanofi's Enjaymo For Rare Form Of Anemia
November 17, 2022
Via
Benzinga
Sanofi (SNY) Q3 2022 Earnings Call Transcript
October 28, 2022
SNY earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Sanofi Jumps As Strong Third-Quarter Profit Leads To Guidance Boost
October 28, 2022
Sanofi stock jumped Friday after the company reported better-than-expected profit.
Via
Investor's Business Daily
iPhone Pro Shipments May Miss Consensus, Tesla Rival Charts Ambitious Expansion Plan In Mexico, Amazon Cloud Unit To Add More Employees: Top Stories Wednesday, Nov. 30
November 30, 2022
Reuters
Via
Benzinga
Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies
November 30, 2022
Via
Benzinga
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi
November 29, 2022
The three companies have until Jan. 10 to decide whether they want to buy Horizon.
Via
Investor's Business Daily
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles
November 18, 2022
Via
Benzinga
Dupixent, Flu Vaccine Demand Boost Sanofi's Q3 Earnings, Lifts Annual Outlook
October 28, 2022
Via
Benzinga
Daily Stock Analysis: Sanofi - November 2022 Snapshot
November 16, 2022
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company's decided in late 2019 to pull back from the cardio-metabolic...
Via
Talk Markets
A Paradigm Shift In Healthcare Produces A Big Market Opportunity
November 15, 2022
In a couple of years, Dario Heath could easily be a $100M+ company running 60%+ gross margins, be profitable and cash generating.
Via
Talk Markets
Eli Lilly's Twitter Fiasco Continues As Drugmaker Reportedly Pulls 'Millions' In Twitter Ads
November 14, 2022
The fallout from a fake account continued Monday as Lilly reportedly pulled Twitter ads.
Via
Investor's Business Daily
Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
November 14, 2022
Learn More about Organicell Regenerative Medicine, Inc. by gaining access to the latest research report In the medical community, the popularity of regenerative medicine is reportedly soaring primarily...
Via
Benzinga
Week In Review: Insilico Signs Six-Drug Discovery Deal With Sanofi Worth Up To $1.2 Billion
November 12, 2022
Insilico Medicine signed a six-drug research collaboration with Sanofi that could be worth up to $1.2 billion. Insilico will receive up to $21.5 million in upfront and target nomination fees for each...
Via
Talk Markets
2 Top Biotech Stocks to Buy in November
November 12, 2022
Both of these companies have potential catalysts on the way.
Via
The Motley Fool
Eli Lilly Dives After Fake Twitter Account Promises Free Insulin; Takes Novo Nordisk, Sanofi With It
November 11, 2022
A fake, but verified, Twitter account impersonated Eli Lilly and claimed insulin is free.
Via
Investor's Business Daily
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
Via
Benzinga
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
November 10, 2022
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen.
Via
Investor's Business Daily
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
November 04, 2022
Via
Benzinga
Why Is Provention Biosciences (PRVB) Stock Up 25% Today?
November 03, 2022
Provention Biosciences shares are trending after reporting earnings. PRVB stock is also up 25% on hopes of FDA approval for teplizumab.
Via
InvestorPlace
Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization From Next Year: Top Stories Tuesday, Nov. 01
November 01, 2022
Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production
Via
Benzinga
Sanofi: Q3 Earnings Insights
October 28, 2022
Sanofi (NASDAQ:SNY) reported its Q3 earnings results on Friday, October 28, 2022 at 05:00 AM. Here's what investors need to know about the announcement. Earnings Sanofi beat estimated earnings by...
Via
Benzinga
Sanofi's Earnings Outlook
October 27, 2022
Sanofi (NASDAQ:SNY) is set to give its latest quarterly earnings report on Friday, 2022-10-28. Here's what investors need to know before the announcement. Analysts estimate that Sanofi will report an...
Via
Benzinga
3 Dividend Stocks That Could Soar 51% to 58%, According to Wall Street
October 24, 2022
Two of these three pay especially attractive dividends.
Via
The Motley Fool
US Stock Futures Lower Following Friday's Rally; Tesla In Focus
October 24, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Monday after recording sharp gains in the previous session. The Dow Jones jumped by around 750 points on Friday. All the...
Via
Benzinga
Earnings Scheduled For October 28, 2022
October 28, 2022
Companies Reporting Before The Bell • TAL Education (NYSE:TAL) is projected to report quarterly earnings at $0.01 per share on revenue of $242.62 million.
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.